Evidence map›Paper›PMID 24822175›Full record

ArticleBioMed research international2014

Perinatal pharmacology.

Karel Allegaert, Vassilios Fanos, Johannes N van den Anker, Stephanie Laër

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karel AllegaertDepartment of Development and Regeneration, KU Leuven and Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
Vassilios FanosDepartment of Surgery, Section of Neonatal Intensive Care Unit, Puericulture Institute and Neonatal Section, University of Cagliari, Cagliari, Italy.
Johannes N van den AnkerDepartments of Pediatrics, Pharmacology, Physiology, and Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington DC, USA ; Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands ; Department of Pediatric Pharmacology, University Children's Hospital Basel, Basel, Switzerland.
Stephanie LaërDepartment of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University of Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Funding

Preclinical dosing optimization: Dosing schedule, tissueU54HD071601 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VAN DEN ANKER, JOHN NICOLAAS · 2011 to 2015
$4.0M
Optimizing the Use of Morphine in Preterm InfantsR01HD048689 · NICHD · CHILDREN'S NATIONAL MEDICAL CENTER · PI VAN DEN ANKER, JOHANNES NICOLAAS · 2005 to 2009
$1.5M
Optimizing the Use of Methadone in Newborn InfantsK24DA027992 · NIDA · CHILDREN'S RESEARCH INSTITUTE · PI VAN DEN ANKER, JOHANNES NICOLAAS · 2010 to 2014
$878k
NICHD NIH HHS R01 HD048689NICHD NIH HHS R01HD048689NICHD NIH HHS U54 HD071601NICHD NIH HHS U54HD071601NIDA NIH HHS K24 DA027992NIDA NIH HHS K24DA027992
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Perinatal CarePerinatologyPharmacokineticsPharmacology, ClinicalFemaleHumansInfant, NewbornPregnancy

Identifiers

PMID24822175
PMCPMC4005049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.